In patients with T2DM, GLP-1 secretion is reduced and the activity of its receptor signaling path-way is diminished, resulting in insufficient stimulation of insulin secretion and progressive decline of β-cell function [111,112]. This evidence concerns the gene GCG and type 2 diabetes mellitus.